#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15540	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2096	737.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1426	1426	C	878	C	817	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28694	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3441	830.4	0	.	n	.	0	T695C	SNP	695	695	T	995	995	C	864	C,T	788,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28694	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3441	830.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1637	1637	A	956	A,G	892,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28694	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3441	830.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2271	2271	C	873	C	797	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28694	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3441	830.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2345	2345	A	881	A	831	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28694	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3441	830.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2897	2897	C	902	C	845	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2016	folP	855	855	99.88	folP.l15.c4.ctg.1	1446	138.7	1	SNP	p	R229S	1	.	.	685	687	AGC	948	950	AGC	201;201;203	A,G;G;C	184,1;185;185	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4886	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3295	147.6	1	SNP	p	S91F	1	.	.	271	273	TTC	523	525	TTC	173;173;172	T;T;C	161;160;159	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4886	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3295	147.6	1	SNP	p	D95G	1	.	.	283	285	GGC	535	537	GGC	164;162;162	G;G;C	156;152;152	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4886	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3295	147.6	1	SNP	p	G95N	0	.	.	283	285	GGC	535	537	GGC	164;162;162	G;G;C	156;152;152	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1636	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1323	123.1	1	SNP	p	G45D	0	.	.	133	135	GGC	433	435	GGC	213;213;214	G;G;C	198;196;194	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	788	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	943	83.1	0	.	n	.	0	A197.	DEL	197	197	A	620	620	A	192	A	177	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5230	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2892	180.2	1	SNP	p	D86N	0	.	.	256	258	GAC	498	500	GAC	192;192;190	G;A;C	177;171;172	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5230	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2892	180.2	1	SNP	p	R87W	0	.	.	259	261	CGT	501	503	CGT	189;190;188	C;G;T	173;174;173	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5230	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2892	180.2	1	SNP	p	R87I	0	.	.	259	261	CGT	501	503	CGT	189;190;188	C;G;T	173;174;173	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5230	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2892	180.2	1	SNP	p	S87R	1	.	.	259	261	CGT	501	503	CGT	189;190;188	C;G;T	173;174;173	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5230	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2892	180.2	1	SNP	p	S88P	0	.	.	262	264	TCC	504	506	TCC	188;189;189	T;C;C	172;170;174	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_W_01411c	parE.WHO_W_01411c	1	1	27	4208	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2593	161.5	1	SNP	p	G410V	0	.	.	1228	1230	GGT	1546	1548	GGT	216;212;212	G,A;G;T	196,1;196;192	parE.WHO_W_01411c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2390	159.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1224	1226	GCA	209;209;208	G;C;A	191;191;193	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2390	159.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1227	1229	ATC	208;209;211	A;T;C	190;195;195	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2390	159.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1239	1241	GTG	208;210;211	G;T;G	195;193;197	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2390	159.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1239	1241	GTG	208;210;211	G;T;G	195;193;197	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2390	159.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1743	1745	ACC	207;208;210	A;C;C	187;193;196	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2390	159.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1797	1799	GCG	203;201;203	G;C,T;G	176;154,1;165	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2390	159.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1797	1799	GCG	203;201;203	G;C,T;G	176;154,1;165	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2390	159.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1920	1922	AGC	188;185;186	A;G;C	176;174;176	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2390	159.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1929	1931	GGC	172;167;165	G;G;C	161;156;151	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3824	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2390	159.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1947	1949	CCG	145;148;143	C,G;C,G;G	106,6;111,2;106	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5666	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3013	187.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1583	1585	CCG	179;180;180	C;C,T;G	158;164,1;162	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2038	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1761	114.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	556	556	C	153	C	136	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	T18M	NONSYN	52	54	ACG	330	332	ATG	236;239;240	A;T,C;G	209;209,2;212	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	E48G	NONSYN	142	144	GAA	420	422	GGA	242;239;245	G;G;A	209;209;210	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	V75I	NONSYN	223	225	GTT	501	503	ATT	225;225;224	A;T;T	211;210;209	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	543	545	AGC	213;215;215	A;G;C,T,A	194;199;196,1,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	V98I	NONSYN	292	294	GTC	570	572	ATC	221;215;215	A;T;C	205;198;200	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	V109A	NONSYN	325	327	GTC	603	605	GCC	233;233;232	G;C;C	196;199;206	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	A121S	NONSYN	361	363	GCC	639	641	AGC	238;237;236	A;G;C,A	210;217;212,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	642	644	AAA	235;237;240	A;A;A	215;220;222	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	R143E	NONSYN	427	429	AGA	705	707	GAA	250;249;253	G;A;A	222;220;224	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	G189N	NONSYN	565	567	GGC	843	845	AAC	269;269;271	A;A;C	247;246;251	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2982	porB1b	1035	1035	96.85	porB1b.l15.c17.ctg.1	1467	201.6	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	909	909	T	270	T	242	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11446	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4840	235.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1382	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1064	129.3	1	SNP	p	V57M	1	.	.	169	171	ATG	534	536	ATG	294;293;292	A;T,C;G	275;273,1;275	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
